The diagnostic "gold standard" in oncology: Increasing importance and increasing concerns Maurie Markman Editor’s Commentary Pages: 237 - 238
Second-line therapy for advanced non-small-cell lung cancer Christine L. HannJulie R. Brahmer OriginalPaper Pages: 243 - 247
Genomic signatures in non-small-cell lung cancer: Targeting the targeted therapies Holly K. DressmanAndrea BildAnil Potti OriginalPaper Pages: 252 - 257
Second-line treatment of small-cell lung cancer Cecilia MacCallumHeidi H. Gillenwater OriginalPaper Pages: 258 - 264
Denosumab in postmenopausal women with low bone mineral density Charles L. Loprinzi Clinical Trials Report Pages: 267 - 268
New agents, new rashes: An update on skin complications from cancer chemotherapy Smitha PatiyilS. Ni ChanAminah Jatoi OriginalPaper Pages: 269 - 274
Antidepressant use in ambulatory cancer patients H. Florence KimMichael J. Fisch OriginalPaper Pages: 275 - 281
Methadone for treatment of cancer pain John BrysonAnoo TamberCamilla Zimmermann OriginalPaper Pages: 282 - 288
Targeted therapy for dermatofibrosarcoma protuberans Thomas A. AbramsScott M. Schuetze OriginalPaper Pages: 291 - 296
Surgical management of spinal mesenchymal tumors Milan G. ModyGanesh RaoLaurence D. Rhines OriginalPaper Pages: 297 - 304
The role of hyperthermia in combined treatment in the management of soft tissue sarcoma Rolf D. IsselsMarcus SchlemmerLars H. Lindner OriginalPaper Pages: 305 - 309
Novel therapeutic approaches in pediatric and young adult sarcomas Peter M. AndersonMargaret Pearson OriginalPaper Pages: 310 - 315